688488.SS · 艾迪药业
China A-shares · RS rating 42 · As of 2026-10-14
| Price | 13.95 CNY |
|---|---|
| 1-day change | -4.3% |
| RS rating (overall / 1M / 3M / 12M) | 42 / 30 / 50 / 63 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 28 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +5.5% |
| Distance from 52-week high | +37.0% |
| Market cap (USD) | $967.8M |